We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Guidance Clarifies Agency Regs v. Revised Common Rule
FDA Guidance Clarifies Agency Regs v. Revised Common Rule
The FDA released new guidance on how researchers can comply with both agency regulations and pending Common Rule revisions that protect human subjects in clinical trials.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor